Colgate-Palmolive vs Ambev
Colgate-Palmolive vs Ambev is a page that compares business models, financial performance, and market context between the two companies. It presents neutral information on how each operates and the environments in which they compete. The aim is to inform readers with clear, accessible language, not to advocate any view. Educational content, not financial advice.
Colgate-Palmolive vs Ambev is a page that compares business models, financial performance, and market context between the two companies. It presents neutral information on how each operates and the en...
Why It's Moving
CL Faces Analyst Warnings of -8% Downside Despite Dividend Boost and Board Refresh
- Dividend increase to $0.53 per share (annualized $2.12) underscores 131 years of uninterrupted payouts, reinforcing reliability for income-focused investors.
- Election of Bristol Myers Squibb CEO Christopher Boerner to the board effective March 15 brings pharma expertise, while Steven Cahillane steps down after strong service.
- Consensus 'Moderate Buy' rating from brokerages contrasts with downside warnings, highlighting mixed views on valuation in a low-volatility staples environment.
ABEV Shares Slide 4% Amid Mixed Signals in Volatile Trading
- Stock tumbled from $2.99 to $2.87 on Thursday, signaling potential profit-taking after recent gains, with key support at $2.38-$2.41.
- Treasury share deliveries in February reduced holdings to 144.9M common shares, a routine move to fulfill restricted stock obligations that underscores steady employee incentive programs.
- Short interest steady at 1.02% of float with a 3.2 days-to-cover ratio, indicating mild bearish bets but no overwhelming pessimism in the near term.
CL Faces Analyst Warnings of -8% Downside Despite Dividend Boost and Board Refresh
- Dividend increase to $0.53 per share (annualized $2.12) underscores 131 years of uninterrupted payouts, reinforcing reliability for income-focused investors.
- Election of Bristol Myers Squibb CEO Christopher Boerner to the board effective March 15 brings pharma expertise, while Steven Cahillane steps down after strong service.
- Consensus 'Moderate Buy' rating from brokerages contrasts with downside warnings, highlighting mixed views on valuation in a low-volatility staples environment.
ABEV Shares Slide 4% Amid Mixed Signals in Volatile Trading
- Stock tumbled from $2.99 to $2.87 on Thursday, signaling potential profit-taking after recent gains, with key support at $2.38-$2.41.
- Treasury share deliveries in February reduced holdings to 144.9M common shares, a routine move to fulfill restricted stock obligations that underscores steady employee incentive programs.
- Short interest steady at 1.02% of float with a 3.2 days-to-cover ratio, indicating mild bearish bets but no overwhelming pessimism in the near term.
Investment Analysis
Pros
- Colgate-Palmolive reported revenue growth of 3.31% in 2024, reaching $20.10 billion, indicating steady top-line expansion.
- The company has strong brand diversification across oral care, personal care, home care, and pet nutrition segments, supporting market resilience.
- Colgate-Palmolive maintains a solid dividend yield around 2.7%, offering a consistent income stream for shareholders.
Considerations
- Colgate-Palmolive's stock has shown limited price appreciation over the past year, which may be unattractive for growth-focused investors.
- The company has a relatively high debt-to-equity ratio, which raises concerns about its financial leverage and risk exposure.
- Its price-to-earnings (P/E) ratio near 22 suggests potential overvaluation compared to peers, limiting upside from current levels.
Ambev
ABEV
Pros
- Ambev is a leading beverage company in Latin America with strong market share in beer and soft drinks, benefiting from regional brand loyalty and scale.
- The company has demonstrated growth potential driven by premium product launches and expansion in emerging markets with rising consumer incomes.
- Ambev maintains efficient production and distribution infrastructure, supporting operational margins despite commodity price volatility.
Considerations
- Ambev faces currency volatility risks due to significant exposure to emerging markets with fluctuating exchange rates impacting earnings.
- The company's performance is sensitive to regulation and taxation changes in the alcoholic beverages sector, which can constrain profitability.
- Economic slowdown or reduced consumer spending in key Latin American markets poses demand risks given Ambev's market concentration.
Related Market Insights
Why Familiar Brands Could Be Your Gateway to Stock Market Success
Nervous about investing? Discover how familiar consumer brands like Coca-Cola, PepsiCo & Ambev offer stability, dividends, and an accessible entry point to the stock market. Start with Nemo from £1.
Aimee Silverwood | Financial Analyst
October 13, 2025
Related Market Insights
Why Familiar Brands Could Be Your Gateway to Stock Market Success
Nervous about investing? Discover how familiar consumer brands like Coca-Cola, PepsiCo & Ambev offer stability, dividends, and an accessible entry point to the stock market. Start with Nemo from £1.
Aimee Silverwood | Financial Analyst
October 13, 2025
Colgate-Palmolive (CL) Next Earnings Date
Colgate-Palmolive (CL) is expected to report its next earnings for the first quarter of 2026 in late April or early May, aligning with its historical quarterly pattern following the Q4 2025 release. The specific date has not been confirmed, but investors should monitor for the official announcement typically issued a few weeks prior. This report will cover the quarter ending March 31, 2026.
Ambev (ABEV) Next Earnings Date
Ambev S.A. (ABEV) is projected to report its Q1 2026 earnings on or around early May 2026, with estimates clustering near May 5-7. This follows the company's historical pattern of releasing first-quarter results in early May, as seen in prior years. Investors should monitor for official confirmation, typically issued closer to the date.
Colgate-Palmolive (CL) Next Earnings Date
Colgate-Palmolive (CL) is expected to report its next earnings for the first quarter of 2026 in late April or early May, aligning with its historical quarterly pattern following the Q4 2025 release. The specific date has not been confirmed, but investors should monitor for the official announcement typically issued a few weeks prior. This report will cover the quarter ending March 31, 2026.
Ambev (ABEV) Next Earnings Date
Ambev S.A. (ABEV) is projected to report its Q1 2026 earnings on or around early May 2026, with estimates clustering near May 5-7. This follows the company's historical pattern of releasing first-quarter results in early May, as seen in prior years. Investors should monitor for official confirmation, typically issued closer to the date.
Which Baskets Do They Appear In?
Familiar brands might ease stock market anxiety?
Investing in familiar global brands can make the stock market feel more accessible and understandable for many Brazilians. This basket offers exposure to the US and EU-listed parent companies behind the everyday consumer products found in homes across Brazil.
Published: October 13, 2025
Explore BasketWhich Baskets Do They Appear In?
Familiar brands might ease stock market anxiety?
Investing in familiar global brands can make the stock market feel more accessible and understandable for many Brazilians. This basket offers exposure to the US and EU-listed parent companies behind the everyday consumer products found in homes across Brazil.
Published: October 13, 2025
Explore BasketBuy CL or ABEV in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Comparisons
Colgate-Palmolive vs Kroger
A neutral Colgate-Palmolive vs Kroger stock comparison outlining business models, financial performance and market context to guide research decisions.
Colgate-Palmolive vs Diageo
A neutral, factual comparison of Colgate-Palmolive Co. and Diageo plc, examining business models, recent financial performance, and market context without advocacy.
Colgate-Palmolive vs Kimberly-Clark
Colgate-Palmolive vs Kimberly-Clark compare business models, revenue, profitability, dividends and market position to help readers research each company.